A61M2202/0417 - CPC Classification Index

ClassID:

23681 ⎘

A61M2202/0417 - CPC Classification

Classification description:

Special media to be introduced, removed or treated; Liquids; Blood; Plasma Immunoglobulin

Sub-classes:

A61M2202/0419 » Immunoglobulin G 8

Recent Application in this class:

20250032683

2025-01-30

SYSTEM AND METHOD FOR AGGREGATION AND AUTOLOGOUS USE OF ALPHA 2M MOLECULES TO TREAT RESPIRATORY CONDITIONS

20250025610

2025-01-23

SYSTEM AND METHOD FOR ALLOGENEIC OR XENOGENEIC USE OF ALPHA 2M MOLECULES IN TREATING MEDICAL CONDITIONS

20240197969

2024-06-20

SYSTEM AND METHOD FOR ALLOGENEIC OR XENOGENEIC USE OF ALPHA 2M MOLECULES IN TREATING MEDICAL CONDITIONS

20240100229

2024-03-28

SYSTEM AND METHOD FOR ISOLATION AND AUTOLOGOUS USE OF ALPHA 2M MOLECULES TO TREAT RESPIRATORY CONDITIONS

20230338628

2023-10-26

SYSTEM AND METHOD FOR ISOLATING ALPHA 2M MOLECULES

20230125698

2023-04-27

APHERESIS COLUMN FOR TREATING RHEUMATOID ARTHRITIS

20220395624

2022-12-15

System and method for isolating alpha 2M molecules

20210353776

2021-11-18

IMMUNOADSORPTION

20190269800

2019-09-05

Immunoadsorption

#10

20180169273

2018-06-21

Immunoadsorption

#11

20150219667

2015-08-06

PRE-TRANSPLANT IgG REACTIVITY TO APOPTOTIC CELLS CORRELATES WITH LATE KIDNEY ALLOGRAFT LOSS

#12

20100285044

2010-11-11

METHOD AND COMPOSITIONS FOR TREATMENT OF CANCERS

#13

20090112146

2009-04-30

Kit, system and method of treating myeloma patients

#14

20080057060

2008-03-06

Method and system to remove cytokine inhibitors in patients

#15

20070087029

2007-04-19

Localized delivery to the lymphatic system

#16

20050244371

2005-11-03

Method and system to remove cytokine inhibitor in patients